PublISHED ON 16 April 2021

UpDATED ON 16 April 2021

European Commission announces rapid funding for research into new variants of coronavirus

More knowledge about new varieties of coronavirus is urgently needed. The European Commission is therefore mobilising €123 million from Horizon Europe for four calls focusing on COVID-19 and new variants of the coronavirus. The last application date for all calls is 6 May 2021.

The initiative is the first of its kind under the new research and innovation program Horizon Europe. It contributes to the European Commission's overall actions to prevent, mitigate and respond to the impacts of coronavirus variants, in line with the new European defence preparedness plan HERA Incubator.

Horizon Infra 2021 Emergency-01

FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases.external link

Horizon Infra 2021 Emergency-02

Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics.external link

Horizon HLTH 2021 Corona 01-01

Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment.external link

Horizon HLTH 2021 Corona 01-02

Cohorts united against COVID-19 variants of concern.external link

PUBLISHED ON 16 April 2021

UpDATED ON 16 April 2021


  1. Interview training for the ERC Starting grant

    The Swedish Research Council is organising a three part workshop series for European Research Council (ERC) Starting grant (StG) candidates to obtain advice and inspiration for ERC StG and interviews. Researchers applying with Swedish universities as...

  2. Apply for funding from Horizon Europe

    The first calls for proposals in the EU's new framework program for research and innovation have now opened. The main work program of Horizon Europe for the period 2021–2022 has a budget of a total of 14.7 billion euro. Information meetings about the...

  3. 100 million SEK for follow-up studies of COVID-19 vaccines

    Six research environments will share a total of 100 million SEK for follow-up studies of COVID-19 vaccines. The research environments are based on collaborations between different regions, and will focus on different aspects of health and medical car...